| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium channel activity | 3.66e-06 | 52 | 90 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.35e-06 | 26 | 90 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.21e-05 | 238 | 90 | 8 | GO:0016747 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.01e-05 | 2 | 90 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.01e-05 | 2 | 90 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 6.01e-05 | 3 | 90 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 6.88e-05 | 18 | 90 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 8.14e-05 | 19 | 90 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.24e-04 | 171 | 90 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.28e-04 | 22 | 90 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.25e-04 | 459 | 90 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor | 2.98e-04 | 6 | 90 | 2 | GO:0004468 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.27e-04 | 78 | 90 | 4 | GO:0008080 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB2 GABRG1 TRPM4 SCN11A ATP6V1H SLC12A3 HCN4 SCN3A PKD1 SCN10A GABRA1 | 5.95e-04 | 758 | 90 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | channel activity | 5.99e-04 | 525 | 90 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.07e-04 | 526 | 90 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | transporter activity | GABRB2 GABRG1 TRPM4 SCN11A SLC35A3 ATP6V1H ABCA4 SLC12A3 HCN4 SCN3A PKD1 SCN10A OSBPL10 APOB GABRA1 | 6.10e-04 | 1289 | 90 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB2 GABRG1 TRPM4 SCN11A ATP6V1H SLC12A3 HCN4 SCN3A PKD1 SCN10A GABRA1 | 8.63e-04 | 793 | 90 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 1.08e-03 | 11 | 90 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.17e-03 | 102 | 90 | 4 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.26e-03 | 104 | 90 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.49e-03 | 50 | 90 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.52e-03 | 13 | 90 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | antigen binding | 1.69e-03 | 190 | 90 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 1.76e-03 | 14 | 90 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.81e-03 | 193 | 90 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.96e-03 | 55 | 90 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.98e-03 | 197 | 90 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.03e-03 | 15 | 90 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB2 GABRG1 TRPM4 SCN11A SLC35A3 ATP6V1H ABCA4 SLC12A3 HCN4 SCN3A PKD1 SCN10A GABRA1 | 2.37e-03 | 1180 | 90 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 2.40e-03 | 59 | 90 | 3 | GO:0008374 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.47e-03 | 125 | 90 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.52e-03 | 60 | 90 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 2.54e-03 | 775 | 90 | 10 | GO:0016746 | |
| GeneOntologyMolecularFunction | membrane insertase activity | 2.61e-03 | 17 | 90 | 2 | GO:0032977 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.16e-03 | 65 | 90 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.16e-03 | 65 | 90 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 3.62e-03 | 20 | 90 | 2 | GO:0050811 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.99e-03 | 21 | 90 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.02e-03 | 334 | 90 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.57e-03 | 343 | 90 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.85e-03 | 151 | 90 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.04e-03 | 465 | 90 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 5.09e-03 | 77 | 90 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.20e-03 | 24 | 90 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 5.28e-03 | 78 | 90 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 5.66e-03 | 80 | 90 | 3 | GO:0008186 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 5.06e-07 | 36 | 91 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.10e-05 | 127 | 91 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | macrophage derived foam cell differentiation | 3.17e-05 | 41 | 91 | 4 | GO:0010742 | |
| GeneOntologyBiologicalProcess | foam cell differentiation | 3.84e-05 | 43 | 91 | 4 | GO:0090077 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.16e-05 | 87 | 91 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.73e-05 | 93 | 91 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin metabolic process | 5.76e-05 | 3 | 91 | 2 | GO:0060177 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 5.99e-05 | 153 | 91 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of transcription by RNA polymerase I | 6.99e-05 | 50 | 91 | 4 | GO:0006356 | |
| GeneOntologyBiologicalProcess | calcitonin gene-related peptide receptor signaling pathway | 1.15e-04 | 4 | 91 | 2 | GO:1990408 | |
| GeneOntologyBiologicalProcess | thigmotaxis | 1.15e-04 | 4 | 91 | 2 | GO:0001966 | |
| GeneOntologyBiologicalProcess | response to high light intensity | 1.15e-04 | 4 | 91 | 2 | GO:0009644 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.15e-04 | 4 | 91 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.50e-04 | 114 | 91 | 5 | GO:0050772 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.63e-04 | 62 | 91 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.99e-04 | 121 | 91 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.16e-04 | 275 | 91 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | action potential | 2.66e-04 | 201 | 91 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 3.09e-04 | 30 | 91 | 3 | GO:1904862 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.20e-04 | 208 | 91 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 3.76e-04 | 32 | 91 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 3.99e-04 | 7 | 91 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 3.99e-04 | 7 | 91 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 3.99e-04 | 7 | 91 | 2 | GO:0071420 | |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | TGFB1 IGKV1-39 IGKV1-27 TRPM4 IGKV1-9 IGKV1D-39 SUCNR1 IGKV4-1 | 4.10e-04 | 403 | 91 | 8 | GO:0002440 |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 4.14e-04 | 79 | 91 | 4 | GO:0006360 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 4.50e-04 | 34 | 91 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 4.91e-04 | 35 | 91 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 4.91e-04 | 35 | 91 | 3 | GO:0007214 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 4.91e-04 | 35 | 91 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | collateral sprouting | 5.79e-04 | 37 | 91 | 3 | GO:0048668 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB2 GABRG1 TRPM4 SCN11A PTPA HCN4 SCN3A PKD1 SCN10A PORCN CATSPERB CATSPERG GABRA1 | 1.27e-08 | 378 | 93 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB2 GABRG1 TRPM4 SCN11A PTPA ATP6V1H HCN4 SCN3A PKD1 SCN10A PORCN CATSPERB CATSPERG GABRA1 | 7.68e-08 | 523 | 93 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | GABRB2 GABRG1 TRPM4 SCN11A PTPA ATP6V1H HCN4 SCN3A PKD1 SCN10A PORCN CATSPERB CATSPERG GABRA1 | 1.42e-07 | 550 | 93 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | cation channel complex | 1.04e-06 | 235 | 93 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | sodium channel complex | 8.01e-06 | 29 | 93 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | membrane protein complex | GABRB2 GABRG1 TRPM4 TRAV7 SCN11A PTPA ATP6V1H EMC1 HCN4 SCN3A PKD1 SCN10A PORCN CATSPERB C7 CALCRL EMC2 CATSPERG GABRA1 | 2.75e-05 | 1498 | 93 | 19 | GO:0098796 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.54e-05 | 17 | 93 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 7.84e-05 | 19 | 93 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.07e-04 | 21 | 93 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | C-fiber | 1.17e-04 | 4 | 93 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.16e-04 | 73 | 93 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | EMC complex | 8.61e-04 | 10 | 93 | 2 | GO:0072546 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 8.80e-04 | 166 | 93 | 5 | GO:0019814 | |
| GeneOntologyCellularComponent | U2-type catalytic step 1 spliceosome | 1.72e-03 | 14 | 93 | 2 | GO:0071006 | |
| GeneOntologyCellularComponent | catalytic step 1 spliceosome | 1.72e-03 | 14 | 93 | 2 | GO:0071012 | |
| GeneOntologyCellularComponent | CatSper complex | 1.98e-03 | 15 | 93 | 2 | GO:0036128 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.10e-03 | 57 | 93 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | TRAV7 SCN11A HCN4 SCN3A SCN10A PORCN CATSPERB C7 CALCRL CATSPERG | 2.56e-03 | 785 | 93 | 10 | GO:0098797 |
| Domain | Na_channel_asu | 1.23e-05 | 10 | 89 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.23e-05 | 10 | 89 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.23e-05 | 10 | 89 | 3 | PF06512 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.25e-05 | 2 | 89 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 2.25e-05 | 2 | 89 | 2 | SM00551 | |
| Domain | - | 2.25e-05 | 2 | 89 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.25e-05 | 2 | 89 | 2 | IPR010303 | |
| Domain | - | 2.25e-05 | 2 | 89 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 2.25e-05 | 2 | 89 | 2 | PF09030 | |
| Domain | zf-TAZ | 2.25e-05 | 2 | 89 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.25e-05 | 2 | 89 | 2 | PS50134 | |
| Domain | KAT11 | 2.25e-05 | 2 | 89 | 2 | SM01250 | |
| Domain | Znf_TAZ | 2.25e-05 | 2 | 89 | 2 | IPR000197 | |
| Domain | KIX | 2.25e-05 | 2 | 89 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 2.25e-05 | 2 | 89 | 2 | PF08214 | |
| Domain | KIX | 2.25e-05 | 2 | 89 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 2.25e-05 | 2 | 89 | 2 | IPR031162 | |
| Domain | DUF902 | 2.25e-05 | 2 | 89 | 2 | PF06001 | |
| Domain | - | 2.25e-05 | 2 | 89 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.25e-05 | 2 | 89 | 2 | IPR013178 | |
| Domain | KIX_dom | 2.25e-05 | 2 | 89 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 2.25e-05 | 2 | 89 | 2 | PS51727 | |
| Domain | EGF-like_dom | 2.48e-05 | 249 | 89 | 8 | IPR000742 | |
| Domain | EGF_1 | 2.94e-05 | 255 | 89 | 8 | PS00022 | |
| Domain | EGF-like_CS | 3.47e-05 | 261 | 89 | 8 | IPR013032 | |
| Domain | - | 3.49e-05 | 39 | 89 | 4 | 2.120.10.30 | |
| Domain | EGF_2 | 3.87e-05 | 265 | 89 | 8 | PS01186 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.75e-05 | 46 | 89 | 4 | IPR011042 | |
| Domain | Sushi | 1.10e-04 | 52 | 89 | 4 | PF00084 | |
| Domain | CCP | 1.27e-04 | 54 | 89 | 4 | SM00032 | |
| Domain | EGF_3 | 1.31e-04 | 235 | 89 | 7 | PS50026 | |
| Domain | Tox-GHH_dom | 1.34e-04 | 4 | 89 | 2 | IPR028916 | |
| Domain | Tox-GHH | 1.34e-04 | 4 | 89 | 2 | PF15636 | |
| Domain | Ten_N | 1.34e-04 | 4 | 89 | 2 | IPR009471 | |
| Domain | Ten_N | 1.34e-04 | 4 | 89 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.34e-04 | 4 | 89 | 2 | PS51361 | |
| Domain | SUSHI | 1.46e-04 | 56 | 89 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.57e-04 | 57 | 89 | 4 | IPR000436 | |
| Domain | GABAA/Glycine_rcpt | 1.73e-04 | 23 | 89 | 3 | IPR006028 | |
| Domain | Ion_trans_dom | 2.14e-04 | 114 | 89 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.14e-04 | 114 | 89 | 5 | PF00520 | |
| Domain | YD | 2.22e-04 | 5 | 89 | 2 | IPR006530 | |
| Domain | Nuc_rcpt_coact | 3.33e-04 | 6 | 89 | 2 | IPR009110 | |
| Domain | - | 3.33e-04 | 6 | 89 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 3.33e-04 | 6 | 89 | 2 | IPR027295 | |
| Domain | EGF | 9.06e-04 | 235 | 89 | 6 | SM00181 | |
| Domain | MBOAT | 1.20e-03 | 11 | 89 | 2 | PF03062 | |
| Domain | MBOAT_fam | 1.20e-03 | 11 | 89 | 2 | IPR004299 | |
| Domain | Tyr_kinase_rcpt_2_CS | 1.20e-03 | 11 | 89 | 2 | IPR002011 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.28e-03 | 45 | 89 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 1.37e-03 | 46 | 89 | 3 | PF02932 | |
| Domain | RWD-domain | 1.44e-03 | 12 | 89 | 2 | IPR006575 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.44e-03 | 12 | 89 | 2 | PS00239 | |
| Domain | Neurotrans-gated_channel_TM | 1.46e-03 | 47 | 89 | 3 | IPR006029 | |
| Domain | - | 1.46e-03 | 47 | 89 | 3 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 1.46e-03 | 47 | 89 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.46e-03 | 47 | 89 | 3 | PS00236 | |
| Domain | Neur_channel | 1.46e-03 | 47 | 89 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.46e-03 | 47 | 89 | 3 | IPR006202 | |
| Domain | NHL | 1.69e-03 | 13 | 89 | 2 | PS51125 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.06e-03 | 53 | 89 | 3 | IPR011047 | |
| Domain | Channel_four-helix_dom | 2.54e-03 | 57 | 89 | 3 | IPR027359 | |
| Domain | - | 2.54e-03 | 57 | 89 | 3 | 1.20.120.350 | |
| Domain | DUF1605 | 2.91e-03 | 17 | 89 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 2.91e-03 | 17 | 89 | 2 | PF07717 | |
| Domain | ZF_ZZ_2 | 3.27e-03 | 18 | 89 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.27e-03 | 18 | 89 | 2 | PS01357 | |
| Domain | ZZ | 3.27e-03 | 18 | 89 | 2 | PF00569 | |
| Domain | HA2 | 3.27e-03 | 18 | 89 | 2 | SM00847 | |
| Domain | HA2 | 3.27e-03 | 18 | 89 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 3.27e-03 | 18 | 89 | 2 | IPR007502 | |
| Domain | Znf_ZZ | 3.64e-03 | 19 | 89 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.64e-03 | 19 | 89 | 2 | SM00291 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 4.76e-05 | 38 | 75 | 4 | M39854 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 9.32e-05 | 17 | 75 | 3 | MM1509 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.32e-04 | 19 | 75 | 3 | M18933 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.72e-04 | 98 | 75 | 5 | M27152 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.78e-04 | 53 | 75 | 4 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 2.05e-04 | 55 | 75 | 4 | M39351 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.70e-04 | 59 | 75 | 4 | M39886 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.76e-04 | 5 | 75 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 2.76e-04 | 5 | 75 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 2.76e-04 | 5 | 75 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 2.76e-04 | 5 | 75 | 2 | M27228 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 2.76e-04 | 5 | 75 | 2 | M48304 | |
| Pathway | REACTOME_FERTILIZATION | 3.44e-04 | 26 | 75 | 3 | M26922 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.13e-04 | 6 | 75 | 2 | M22062 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 4.13e-04 | 6 | 75 | 2 | MM15545 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 4.92e-04 | 69 | 75 | 4 | M27150 | |
| Pathway | REACTOME_REPRODUCTION | 5.30e-04 | 30 | 75 | 3 | MM17211 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 5.76e-04 | 194 | 75 | 6 | M16312 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.76e-04 | 7 | 75 | 2 | MM1573 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 5.84e-04 | 31 | 75 | 3 | M39369 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.84e-04 | 31 | 75 | 3 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 6.42e-04 | 32 | 75 | 3 | M27455 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.66e-04 | 8 | 75 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 7.66e-04 | 8 | 75 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 7.66e-04 | 8 | 75 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 7.66e-04 | 8 | 75 | 2 | M46443 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 7.69e-04 | 34 | 75 | 3 | M39771 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 9.81e-04 | 9 | 75 | 2 | M26935 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 9.81e-04 | 9 | 75 | 2 | M47451 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 9.81e-04 | 9 | 75 | 2 | MM14548 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 1.22e-03 | 10 | 75 | 2 | M27824 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.22e-03 | 10 | 75 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.49e-03 | 11 | 75 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.49e-03 | 11 | 75 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.49e-03 | 11 | 75 | 2 | M26924 | |
| Pathway | PID_HNF3A_PATHWAY | 1.64e-03 | 44 | 75 | 3 | M285 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.78e-03 | 12 | 75 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.78e-03 | 12 | 75 | 2 | M27765 | |
| Pathway | REACTOME_ALK_MUTANTS_BIND_TKIS | 1.78e-03 | 12 | 75 | 2 | M42522 | |
| Pubmed | 2.05e-09 | 20 | 95 | 5 | 10427970 | ||
| Pubmed | 1.70e-08 | 11 | 95 | 4 | 6795447 | ||
| Pubmed | Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis. | 1.70e-08 | 11 | 95 | 4 | 279004 | |
| Pubmed | Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes. | 1.70e-08 | 11 | 95 | 4 | 6767723 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 16428436 | ||
| Pubmed | Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease. | 1.97e-08 | 3 | 95 | 3 | 35855613 | |
| Pubmed | 1.55e-07 | 18 | 95 | 4 | 20399194 | ||
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 12743039 | ||
| Pubmed | 3.68e-07 | 22 | 95 | 4 | 35245678 | ||
| Pubmed | 3.93e-07 | 6 | 95 | 3 | 23711479 | ||
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 6.86e-07 | 7 | 95 | 3 | 10449790 | |
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 6.86e-07 | 7 | 95 | 3 | 24440715 | |
| Pubmed | 1.09e-06 | 8 | 95 | 3 | 10331952 | ||
| Pubmed | 1.09e-06 | 8 | 95 | 3 | 25101983 | ||
| Pubmed | 1.64e-06 | 9 | 95 | 3 | 16382098 | ||
| Pubmed | 2.34e-06 | 10 | 95 | 3 | 20583128 | ||
| Pubmed | 2.97e-06 | 81 | 95 | 5 | 20301590 | ||
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 22768092 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 7.38e-06 | 2 | 95 | 2 | 34845315 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25348603 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22389491 | ||
| Pubmed | Tuning Macrophage Phenotype to Mitigate Skeletal Muscle Fibrosis. | 7.38e-06 | 2 | 95 | 2 | 32161098 | |
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 7.38e-06 | 2 | 95 | 2 | 29970412 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19729597 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24144460 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 39287984 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21209255 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20717166 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25893291 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11559821 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28912302 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 32576962 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19822209 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24522976 | ||
| Pubmed | Phage display of a human antibody against Clostridium tetani toxin. | 7.38e-06 | 2 | 95 | 2 | 7926831 | |
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 7.38e-06 | 2 | 95 | 2 | 21847097 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28450535 | ||
| Pubmed | Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. | 7.38e-06 | 2 | 95 | 2 | 11331371 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 7.38e-06 | 2 | 95 | 2 | 34813504 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22374302 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23352789 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26197481 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20301699 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24639469 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 7.38e-06 | 2 | 95 | 2 | 11438528 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10918613 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 35502657 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 31898871 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 7.38e-06 | 2 | 95 | 2 | 30888860 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 31534133 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29087248 | ||
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 7.38e-06 | 2 | 95 | 2 | 27881443 | |
| Pubmed | TGFBI gene mutations causing lattice and granular corneal dystrophies in Indian patients. | 7.38e-06 | 2 | 95 | 2 | 15623763 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19272189 | ||
| Pubmed | Induction and expression of betaig-h3 in pancreatic cancer cells. | 7.38e-06 | 2 | 95 | 2 | 12379307 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 7.38e-06 | 2 | 95 | 2 | 32690000 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 30953353 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21803292 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9811832 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24089570 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12490572 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 7.38e-06 | 2 | 95 | 2 | 39266679 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22303793 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 7.38e-06 | 2 | 95 | 2 | 34019788 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15860545 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29460469 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18399542 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 7.38e-06 | 2 | 95 | 2 | 24551300 | |
| Pubmed | TGFBI deficiency predisposes mice to spontaneous tumor development. | 7.38e-06 | 2 | 95 | 2 | 19117985 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33911074 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9018065 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24648406 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 30135524 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38849501 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 7.38e-06 | 2 | 95 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 7.38e-06 | 2 | 95 | 2 | 29217654 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10049825 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 7.38e-06 | 2 | 95 | 2 | 31400758 | |
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 7.38e-06 | 2 | 95 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 7.38e-06 | 2 | 95 | 2 | 29170789 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 7.38e-06 | 2 | 95 | 2 | 12646247 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11867645 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26438821 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38605034 | ||
| Pubmed | Mutation analysis of the TGFBI gene in Vietnamese with granular and Avellino corneal dystrophy. | 7.38e-06 | 2 | 95 | 2 | 14767644 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 7.38e-06 | 2 | 95 | 2 | 11963968 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 37450367 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 7.38e-06 | 2 | 95 | 2 | 12696060 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19931571 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34930944 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16857712 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 7.38e-06 | 2 | 95 | 2 | 36109165 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18615206 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12242694 | ||
| Cytoband | 2p12 | 1.85e-07 | 117 | 96 | 6 | 2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 6.09e-06 | 213 | 96 | 6 | chr2p11 | |
| Cytoband | 5q34 | 4.21e-05 | 32 | 96 | 3 | 5q34 | |
| Cytoband | 9q33.3 | 6.54e-05 | 37 | 96 | 3 | 9q33.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q34 | 8.92e-05 | 41 | 96 | 3 | chr5q34 | |
| Cytoband | 3p22.2 | 1.16e-03 | 24 | 96 | 2 | 3p22.2 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.02e-06 | 9 | 67 | 3 | 1203 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.39e-05 | 83 | 67 | 5 | 351 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 4.52e-05 | 19 | 67 | 3 | 563 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.87e-05 | 57 | 67 | 4 | 1179 | |
| GeneFamily | Cation channels sperm associated | 2.81e-04 | 7 | 67 | 2 | 186 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 7.28e-04 | 11 | 67 | 2 | 559 | |
| GeneFamily | DEAH-box helicases | 1.57e-03 | 16 | 67 | 2 | 500 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.77e-03 | 17 | 67 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.99e-03 | 18 | 67 | 2 | 91 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 9.64e-03 | 40 | 67 | 2 | 321 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.01e-02 | 41 | 67 | 2 | 1298 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | HHIP SLC35A3 SERPINI1 EFNA5 NTRK2 SCN3A TENM1 BCL11A IDE CALCRL CSMD3 CREBBP TENM2 GABRA1 | 8.46e-06 | 818 | 90 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | HHIP SLC35A3 SERPINI1 NTRK2 SCN3A TENM1 BCL11A CALCRL CSMD3 TENM2 | 1.33e-05 | 427 | 90 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-08 | 198 | 96 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 1.44e-07 | 183 | 96 | 7 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 1.44e-07 | 183 | 96 | 7 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 184 | 96 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 184 | 96 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-07 | 184 | 96 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 1.73e-07 | 188 | 96 | 7 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-07 | 196 | 96 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.38e-07 | 197 | 96 | 7 | 1ded28732ea5d1f9ebca0b136575103540600ff1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.46e-07 | 198 | 96 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 2.55e-07 | 199 | 96 | 7 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.63e-07 | 200 | 96 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-06 | 163 | 96 | 6 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.68e-06 | 181 | 96 | 6 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.85e-06 | 183 | 96 | 6 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.95e-06 | 184 | 96 | 6 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.95e-06 | 184 | 96 | 6 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.04e-06 | 185 | 96 | 6 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.13e-06 | 186 | 96 | 6 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.23e-06 | 187 | 96 | 6 | cbe25fb3fc8ed6245dc767c884c298c89a774cce | |
| ToppCell | NS-critical-d_16-33-Myeloid-Non-resident_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.54e-06 | 190 | 96 | 6 | 4fe9654a9b449ef49ca10b973ac4378dab34cb53 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-06 | 190 | 96 | 6 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-06 | 190 | 96 | 6 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.65e-06 | 191 | 96 | 6 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue | 3.99e-06 | 194 | 96 | 6 | e6391bc7073831847c469ef0b0c437118e1f151f | |
| ToppCell | IPF-Myeloid|IPF / Disease state, Lineage and Cell class | 4.11e-06 | 195 | 96 | 6 | fdeb958aeaa00f3fc25c4e59efbbc6f4a572c9ce | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.11e-06 | 195 | 96 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 197 | 96 | 6 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-06 | 112 | 96 | 5 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-06 | 198 | 96 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.49e-06 | 198 | 96 | 6 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.62e-06 | 199 | 96 | 6 | 614c1e788d89310e78984241977941beed8d12dc | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 4.76e-06 | 200 | 96 | 6 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 200 | 96 | 6 | 4657d18e92abde7f0b8b7e4fc9fa0081efe20a55 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 200 | 96 | 6 | 35bbd3fc96c4f249bd79c4c5ad8ee6eb6df32c33 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-06 | 200 | 96 | 6 | 26df6ac63710655604888c3be6509b6c4befc0be | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 200 | 96 | 6 | f1255d4de08134bd0a95296c8cc743e90044d2ff | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 200 | 96 | 6 | c30da72c3581d384b76c95f5989e32a36d783ef3 | |
| ToppCell | Transverse-(6)_Macrophage-(60)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 4.76e-06 | 200 | 96 | 6 | 2be675684a2958ea609939bb45248bede78a26bc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-06 | 200 | 96 | 6 | 07819a90ac347883b78d0bb3cd8c5eb0d66e1e22 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 200 | 96 | 6 | 09bac15df511687ff336c1e7a67d980c6c281f79 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 145 | 96 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.62e-05 | 146 | 96 | 5 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-05 | 158 | 96 | 5 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.44e-05 | 159 | 96 | 5 | 204e5a675f4684c9570c24c8d34bbf632fd8164a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 162 | 96 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.00e-05 | 166 | 96 | 5 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 166 | 96 | 5 | 13027ae342994db4540e64eb910df1f42b160931 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 166 | 96 | 5 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f | |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | 3.27e-05 | 169 | 96 | 5 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.36e-05 | 170 | 96 | 5 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.36e-05 | 170 | 96 | 5 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.36e-05 | 170 | 96 | 5 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.55e-05 | 172 | 96 | 5 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.65e-05 | 173 | 96 | 5 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 3.76e-05 | 174 | 96 | 5 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 3.86e-05 | 175 | 96 | 5 | d73ee324479172501481b54967a0f3bd870fcf3a | |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.97e-05 | 176 | 96 | 5 | 50e207403d48ce1b55a78897adb5519a2430a626 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.97e-05 | 176 | 96 | 5 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.07e-05 | 177 | 96 | 5 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 4.30e-05 | 179 | 96 | 5 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-05 | 181 | 96 | 5 | 768d14c452192f92fa557ae59e84c43436f575f0 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-B_memory|Leuk-UTI / Disease, Lineage and Cell Type | 4.77e-05 | 183 | 96 | 5 | f7a5daec3e8484c7071164a09e9c961fe64d9f81 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 184 | 96 | 5 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | 4.90e-05 | 184 | 96 | 5 | 6f70d8f8ab8362d51f8a58735d42223e06566397 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 185 | 96 | 5 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 185 | 96 | 5 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC2|Liver / Manually curated celltypes from each tissue | 5.16e-05 | 186 | 96 | 5 | 92ef569c8f864d3abaa087cd3ce0366e8f9f50c2 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.16e-05 | 186 | 96 | 5 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.29e-05 | 187 | 96 | 5 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-05 | 188 | 96 | 5 | fbf176b48b89c234e4e1e64739afc836bed78a96 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.43e-05 | 188 | 96 | 5 | c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.56e-05 | 96 | 96 | 4 | 56e993d37b7958abe56682422536045550e29b41 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 5.56e-05 | 189 | 96 | 5 | 6c2ace61a7d62bcf7e76b73e2da8b722d03e713b | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.56e-05 | 189 | 96 | 5 | 2aebea7a6c2f83112d7c504b742f2c04b92e459a | |
| ToppCell | 10x5'-Liver-Lymphocytic_B|Liver / Manually curated celltypes from each tissue | 5.56e-05 | 189 | 96 | 5 | 1ebff8185060d78f27f8d887e9adaa5f8faf2196 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 189 | 96 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 189 | 96 | 5 | 984b5f21e84dd8273d8437ac2a5a9de4e9484b9a | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.85e-05 | 191 | 96 | 5 | 88cb6f828407845918c946f8cee5f940cb81800a | |
| ToppCell | hematopoetic_progenitors-CD34+_CLP|World / Lineage and Cell class | 5.85e-05 | 191 | 96 | 5 | 32f2537c97c9984629d61c6f34a337f555146ad4 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.99e-05 | 192 | 96 | 5 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|COVID-19 / Condition, Lineage and Cell class | 6.14e-05 | 193 | 96 | 5 | bffd97a73365e1dd23ff3b0320b4860f04ec091a | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 6.14e-05 | 193 | 96 | 5 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 6.14e-05 | 193 | 96 | 5 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.14e-05 | 193 | 96 | 5 | 642f8f20e5a35a4b5d1fc8d3f1e3b9b83a37a654 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-05 | 194 | 96 | 5 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.30e-05 | 194 | 96 | 5 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-05 | 194 | 96 | 5 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 194 | 96 | 5 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 194 | 96 | 5 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | (4)_Endothelial_cells-(4)_Lymph_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.30e-05 | 194 | 96 | 5 | 9735b86d3b2480a0b34d8aab8e7bd609d83c2454 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-05 | 194 | 96 | 5 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | (2)_Mono_macro|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.30e-05 | 194 | 96 | 5 | 7c05525614ee8cdfcbf22cce9146a8e73af7d14e | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 6.30e-05 | 194 | 96 | 5 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | MNPs|World / lung cells shred on cell class, cell subclass, sample id | 6.45e-05 | 195 | 96 | 5 | bd84ceae79115afd13346d8d66da30232a0952a9 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 6.45e-05 | 195 | 96 | 5 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | IPF-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 6.45e-05 | 195 | 96 | 5 | 50edda117b438b9c3616191884007466f6d974f0 | |
| Drug | NSC364150 | 3.23e-08 | 48 | 89 | 6 | CID000100771 | |
| Drug | methohexital | 2.18e-06 | 24 | 89 | 4 | CID000009034 | |
| Drug | AC1L1BIT | 3.76e-06 | 60 | 89 | 5 | CID000001457 | |
| Drug | ethanol | TGFB1 GABRB2 SELP GABRG1 SCN11A PTPA CS NTRK2 SCN3A SCN10A APOB EIF2AK3 GABRA1 SMG6 | 4.36e-06 | 837 | 89 | 14 | CID000000702 |
| Drug | tiotidine | 4.77e-06 | 9 | 89 | 3 | ctd:C023990 | |
| Drug | SKF89976A | 6.33e-06 | 31 | 89 | 4 | CID000092409 | |
| Drug | forskolin from Coleus forskohlii | TGFB1 GABRB2 TGFBI GABRG1 PTPA EFNA5 SCN3A SCN10A CALCRL LYZ CREBBP EIF2AK3 EP300 GABRA1 DUOXA2 | 8.33e-06 | 1013 | 89 | 15 | CID000003413 |
| Drug | fosazepam | 9.31e-06 | 11 | 89 | 3 | CID000037114 | |
| Drug | C19H18ClN3O | 9.31e-06 | 11 | 89 | 3 | CID000027452 | |
| Drug | flutoprazepam | 9.31e-06 | 11 | 89 | 3 | CID000003400 | |
| Drug | Arfendazam | 9.31e-06 | 11 | 89 | 3 | CID000065803 | |
| Drug | camazepam | 9.31e-06 | 11 | 89 | 3 | CID000037367 | |
| Drug | Bu-1014 | 9.31e-06 | 11 | 89 | 3 | CID015942721 | |
| Drug | Zapizolam | 9.31e-06 | 11 | 89 | 3 | CID000068832 | |
| Drug | Reclazepam | 9.31e-06 | 11 | 89 | 3 | CID003052777 | |
| Drug | iclazepam | 9.31e-06 | 11 | 89 | 3 | CID000068777 | |
| Drug | menitrazepam | 9.31e-06 | 11 | 89 | 3 | CID000189875 | |
| Drug | etiroxate | 9.31e-06 | 11 | 89 | 3 | CID000065683 | |
| Drug | Serin hydrazid | 9.31e-06 | 11 | 89 | 3 | CID000041637 | |
| Drug | sulazepam | 9.31e-06 | 11 | 89 | 3 | CID000017931 | |
| Drug | elfazepam | 9.31e-06 | 11 | 89 | 3 | CID000065445 | |
| Drug | triflubazam | 9.31e-06 | 11 | 89 | 3 | CID000031157 | |
| Drug | uldazepam | 9.31e-06 | 11 | 89 | 3 | CID000034274 | |
| Drug | gidazepam | 9.31e-06 | 11 | 89 | 3 | CID000121919 | |
| Drug | fletazepam | 9.31e-06 | 11 | 89 | 3 | CID000036834 | |
| Drug | SB-205384 | 1.24e-05 | 12 | 89 | 3 | CID000197690 | |
| Drug | U-93631 | 1.24e-05 | 12 | 89 | 3 | CID000197626 | |
| Drug | haloxazolam | 1.24e-05 | 12 | 89 | 3 | CID000003563 | |
| Drug | doxefazepam | 1.24e-05 | 12 | 89 | 3 | CID000038668 | |
| Drug | pivoxazepam | 1.24e-05 | 12 | 89 | 3 | CID000068722 | |
| Drug | razobazam | 1.24e-05 | 12 | 89 | 3 | CID000071228 | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.28e-05 | 198 | 89 | 7 | 2216_UP | |
| Drug | isoflurane | 1.38e-05 | 279 | 89 | 8 | CID000003763 | |
| Drug | pH Q | 1.46e-05 | 79 | 89 | 5 | CID000007708 | |
| Drug | nerisopam | 1.61e-05 | 13 | 89 | 3 | CID000065875 | |
| Drug | flutazolam | 1.61e-05 | 13 | 89 | 3 | CID000003398 | |
| Drug | 4-PIOL | 1.61e-05 | 13 | 89 | 3 | CID000125520 | |
| Drug | AC1MVFYM | 1.61e-05 | 13 | 89 | 3 | CID003707225 | |
| Drug | Ro 11-3128 | 1.61e-05 | 13 | 89 | 3 | CID000093364 | |
| Drug | cinolazepam | 1.61e-05 | 13 | 89 | 3 | CID003033621 | |
| Drug | alpha IMGBL | 1.61e-05 | 13 | 89 | 3 | CID000131516 | |
| Drug | metaclazepam | 1.61e-05 | 13 | 89 | 3 | CID000071272 | |
| Drug | sodium | GABRB2 AMBP SELP GABRG1 TRPM4 ATP6V1H SLC12A3 SACS SCN3A PKD1 SCN10A PRPF8 LYZ GABRA1 | 1.70e-05 | 944 | 89 | 14 | CID000000923 |
| Drug | beta-CCt | 2.04e-05 | 14 | 89 | 3 | CID000124514 | |
| Drug | Me-lex | 2.04e-05 | 14 | 89 | 3 | CID000004177 | |
| Drug | ethyl loflazepate | 2.04e-05 | 14 | 89 | 3 | CID000003299 | |
| Drug | PK11195 | 2.18e-05 | 42 | 89 | 4 | CID000001345 | |
| Drug | creatinine | 2.43e-05 | 302 | 89 | 8 | CID000000588 | |
| Drug | SR 95103 | 2.54e-05 | 15 | 89 | 3 | CID000125958 | |
| Drug | pinazepam | 2.54e-05 | 15 | 89 | 3 | CID000040391 | |
| Drug | fludiazepam | 2.54e-05 | 15 | 89 | 3 | CID000003369 | |
| Drug | TBOB | 2.54e-05 | 15 | 89 | 3 | CID000114986 | |
| Drug | loprazolam | 2.54e-05 | 15 | 89 | 3 | CID003033860 | |
| Drug | premazepam | 2.54e-05 | 15 | 89 | 3 | CID000072104 | |
| Drug | girisopam | 2.54e-05 | 15 | 89 | 3 | CID000071257 | |
| Drug | Ro 5-4864 | 2.63e-05 | 44 | 89 | 4 | CID000001688 | |
| Drug | pregnanolone | 2.76e-05 | 90 | 89 | 5 | CID000031402 | |
| Drug | procaine | 3.06e-05 | 153 | 89 | 6 | CID000004914 | |
| Drug | tetrazepam | 3.12e-05 | 16 | 89 | 3 | CID000025215 | |
| Drug | P858 | 3.12e-05 | 16 | 89 | 3 | CID000004617 | |
| Drug | nimetazepam | 3.12e-05 | 16 | 89 | 3 | CID000004496 | |
| Drug | Ro 19-4603 | 3.12e-05 | 16 | 89 | 3 | CID000127382 | |
| Drug | heptachlor epoxide | 3.14e-05 | 46 | 89 | 4 | CID000013930 | |
| Drug | flurothyl | 3.42e-05 | 47 | 89 | 4 | CID000009528 | |
| Drug | imidazole-4-acetic acid | 3.72e-05 | 48 | 89 | 4 | CID000096215 | |
| Drug | dihydroxyaflavinine | 3.77e-05 | 17 | 89 | 3 | CID000156857 | |
| Drug | CL 218,872 | 3.77e-05 | 17 | 89 | 3 | CID000107950 | |
| Drug | lidocaine | 3.94e-05 | 160 | 89 | 6 | CID000003676 | |
| Drug | abecarnil | 4.52e-05 | 18 | 89 | 3 | CID000065914 | |
| Drug | cloxazolam | 4.52e-05 | 18 | 89 | 3 | CID000002816 | |
| Drug | clorazepate | 4.52e-05 | 18 | 89 | 3 | CID000002809 | |
| Drug | lormetazepam | 4.52e-05 | 18 | 89 | 3 | CID000013314 | |
| Drug | phenazepam | 4.52e-05 | 18 | 89 | 3 | CID000040113 | |
| Drug | 1-(4-chlorophenyl)piperazine | 4.52e-05 | 3 | 89 | 2 | ctd:C026386 | |
| Drug | NSC326198 | 4.52e-05 | 3 | 89 | 2 | CID005359777 | |
| Drug | 1-(2-methoxyphenyl)piperazine | 4.52e-05 | 3 | 89 | 2 | ctd:C040083 | |
| Drug | PREPARATIONS | 4.52e-05 | 3 | 89 | 2 | CID000019670 | |
| Drug | Bemegride | 4.52e-05 | 3 | 89 | 2 | ctd:D001534 | |
| Drug | menthone | 4.52e-05 | 3 | 89 | 2 | ctd:C019466 | |
| Drug | cyclopentaphenanthrene | 4.52e-05 | 3 | 89 | 2 | ctd:C013460 | |
| Drug | gabazine | 4.52e-05 | 3 | 89 | 2 | ctd:C049853 | |
| Drug | gabapentin | 5.34e-05 | 169 | 89 | 6 | CID000003446 | |
| Drug | etifoxine | 5.35e-05 | 19 | 89 | 3 | CID000030768 | |
| Drug | ZK 93426 | 5.35e-05 | 19 | 89 | 3 | CID000115210 | |
| Drug | titanium | 5.52e-05 | 170 | 89 | 6 | CID000023963 | |
| Drug | halazepam | 6.27e-05 | 20 | 89 | 3 | CID000031640 | |
| Drug | AC1N65YL | 6.27e-05 | 20 | 89 | 3 | CID004229818 | |
| Drug | Ro 15-4513 | 6.27e-05 | 20 | 89 | 3 | CID000005081 | |
| Drug | EBOB | 6.27e-05 | 20 | 89 | 3 | CID000115223 | |
| Drug | riluzole | 6.28e-05 | 174 | 89 | 6 | CID000005070 | |
| Drug | prazepam | 7.30e-05 | 21 | 89 | 3 | CID000004890 | |
| Drug | bicuculline methochloride | 7.30e-05 | 21 | 89 | 3 | CID000123659 | |
| Drug | R 5135 | 7.30e-05 | 21 | 89 | 3 | CID000119544 | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; HL60; HG-U133A | 7.58e-05 | 180 | 89 | 6 | 1765_DN | |
| Drug | NSC7524 | 8.06e-05 | 182 | 89 | 6 | CID000005657 | |
| Drug | Iomazenil (123I | 8.43e-05 | 22 | 89 | 3 | CID000065959 | |
| Drug | quazepam | 8.43e-05 | 22 | 89 | 3 | CID000004999 | |
| Drug | etizolam | 8.43e-05 | 22 | 89 | 3 | CID000003307 | |
| Drug | 6 mEq | 8.43e-05 | 22 | 89 | 3 | CID000126186 | |
| Drug | imidazenil | 8.43e-05 | 22 | 89 | 3 | CID000119194 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.13e-06 | 10 | 89 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.13e-06 | 10 | 89 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.72e-06 | 12 | 89 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TGFB1 HHIP ABCA4 SACS LAMA1 TENM1 APOB CSMD3 SNRNP200 ZEB2 EP300 | 8.67e-06 | 702 | 89 | 11 | C0009402 |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.00e-06 | 2 | 89 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 9.00e-06 | 2 | 89 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 9.00e-06 | 2 | 89 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 9.00e-06 | 2 | 89 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 9.00e-06 | 2 | 89 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 9.00e-06 | 2 | 89 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 9.00e-06 | 2 | 89 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 9.00e-06 | 2 | 89 | 2 | C0035934 | |
| Disease | Mood Disorders | 1.22e-05 | 168 | 89 | 6 | C0525045 | |
| Disease | Primary Erythermalgia | 2.69e-05 | 3 | 89 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.69e-05 | 3 | 89 | 2 | C1833661 | |
| Disease | Obesity | 3.76e-05 | 205 | 89 | 6 | C0028754 | |
| Disease | Brugada Syndrome (disorder) | 5.13e-05 | 24 | 89 | 3 | C1142166 | |
| Disease | Congenital Pain Insensitivity | 1.87e-04 | 7 | 89 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.87e-04 | 7 | 89 | 2 | C0020075 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 2.60e-04 | 41 | 89 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Carcinoma, Transitional Cell | 2.60e-04 | 41 | 89 | 3 | C0007138 | |
| Disease | Retinitis Pigmentosa | 2.82e-04 | 104 | 89 | 4 | C0035334 | |
| Disease | Other specified cardiac arrhythmias | 4.86e-04 | 11 | 89 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 4.86e-04 | 11 | 89 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 4.86e-04 | 11 | 89 | 2 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 4.86e-04 | 11 | 89 | 2 | C2748542 | |
| Disease | Orofacial cleft | 4.97e-04 | 51 | 89 | 3 | HP_0000202 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 5.06e-04 | 216 | 89 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | cerebellar volume measurement | 5.27e-04 | 52 | 89 | 3 | EFO_0020864 | |
| Disease | angina pectoris | 5.67e-04 | 125 | 89 | 4 | EFO_0003913 | |
| Disease | Brugada Syndrome 1 | 6.87e-04 | 13 | 89 | 2 | C4551804 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 9.21e-04 | 15 | 89 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Sinus Node Dysfunction (disorder) | 9.21e-04 | 15 | 89 | 2 | C0428908 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 9.24e-04 | 63 | 89 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | sickle cell anemia (is_implicated_in) | 1.05e-03 | 16 | 89 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 1.19e-03 | 17 | 89 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.19e-03 | 17 | 89 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.19e-03 | 17 | 89 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.19e-03 | 17 | 89 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.19e-03 | 17 | 89 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.19e-03 | 17 | 89 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.19e-03 | 17 | 89 | 2 | C0751781 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.31e-03 | 71 | 89 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | Alcoholic Intoxication, Chronic | 1.33e-03 | 268 | 89 | 5 | C0001973 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.33e-03 | 18 | 89 | 2 | C0751779 | |
| Disease | Schizophrenia | 1.39e-03 | 883 | 89 | 9 | C0036341 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.42e-03 | 160 | 89 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Retinitis pigmentosa | 1.47e-03 | 74 | 89 | 3 | cv:C0035334 | |
| Disease | epilepsy (implicated_via_orthology) | 1.52e-03 | 163 | 89 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 1.54e-03 | 277 | 89 | 5 | C0009404 | |
| Disease | interleukin 18 measurement | 1.59e-03 | 76 | 89 | 3 | EFO_0004581 | |
| Disease | coagulation factor V measurement | 1.65e-03 | 20 | 89 | 2 | EFO_0008087 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.77e-03 | 286 | 89 | 5 | EFO_0004346, EFO_0006930 | |
| Disease | cortical thickness | 1.92e-03 | 1113 | 89 | 10 | EFO_0004840 | |
| Disease | Renal glomerular disease | 2.18e-03 | 23 | 89 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.18e-03 | 23 | 89 | 2 | C4521256 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 2.18e-03 | 23 | 89 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | liver fibrosis measurement | 2.27e-03 | 86 | 89 | 3 | EFO_0010576 | |
| Disease | Septicemia | 2.38e-03 | 24 | 89 | 2 | C0036690 | |
| Disease | Sepsis | 2.38e-03 | 24 | 89 | 2 | C0243026 | |
| Disease | Severe Sepsis | 2.38e-03 | 24 | 89 | 2 | C1719672 | |
| Disease | Pyemia | 2.38e-03 | 24 | 89 | 2 | C0034189 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 2.38e-03 | 24 | 89 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | heart failure | 2.41e-03 | 185 | 89 | 4 | EFO_0003144 | |
| Disease | atopic dermatitis (is_implicated_in) | 2.79e-03 | 26 | 89 | 2 | DOID:3310 (is_implicated_in) | |
| Disease | migraine disorder, pulse pressure measurement | 2.79e-03 | 26 | 89 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.91e-03 | 801 | 89 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 3.01e-03 | 27 | 89 | 2 | DOID:10584 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GTNRKYFTNCKQWYQ | 56 | Q15582 | |
| VQENFNISRIYGKWY | 31 | P02760 | |
| KQDQDYYFFLASNWR | 716 | Q6ZRH7 | |
| TSWGDSRQAQASYYK | 486 | Q86US8 | |
| QASDTANYGKARSWY | 741 | Q86US8 | |
| NNAWLYNRKTSRVYK | 1126 | Q09472 | |
| YNFGQRNGRTWKIYS | 701 | Q9H7T0 | |
| AQNYIWKGSYNFKGR | 3496 | Q7Z407 | |
| SWNDIKNSGYISRYL | 576 | Q9NZJ5 | |
| GSRVLSFNWYEDNNY | 331 | P78363 | |
| QYSRYGFGKSFNSLW | 61 | Q9NP70 | |
| NITWALKRYGFYNNS | 276 | Q5FYB1 | |
| LRTKNEYNLWTAYQN | 371 | Q5XX13 | |
| FNNAWLYNRKTSRVY | 1161 | Q92793 | |
| LANGWQKYLSTLLYN | 591 | Q6ZW61 | |
| TVGGAFYLKQWRSYN | 36 | Q9NX57 | |
| QKRYQDWFQRQYLST | 326 | Q68E01 | |
| KSTGLNFNLHWRFYY | 96 | Q9NWY4 | |
| LRTKNEYNLWTAYQN | 371 | O95170 | |
| RASQSISSYLNWYQQ | 46 | P04432 | |
| GSLWSFNYFFYNKRL | 181 | Q9H063 | |
| KWESGYNTRATNYNA | 51 | P61626 | |
| RFNWLGNFYIVLSYN | 421 | Q8WVP7 | |
| YSQWLAGYAASRQLK | 656 | Q9H165 | |
| VAAKNVALLAYNRWY | 461 | Q8NBM8 | |
| YFFKGKVYWRLNQQL | 441 | Q99542 | |
| FGIFNLVYWATYLNR | 431 | P14867 | |
| YFQQAWRDKRLSYNV | 86 | P47870 | |
| NLYIYFAWQGKTQIS | 151 | O43934 | |
| MVNNSWGKQYSYALF | 456 | Q9Y3Q4 | |
| DLNWQTRKYNTKAAY | 186 | Q8NBN7 | |
| VTYFSLWYYNKQNQR | 61 | Q16825 | |
| YWLNNYVFKNALRLG | 311 | Q9H237 | |
| YNEQFTWRLKENYAA | 126 | Q1HG44 | |
| YLQRKYNDALAWSFG | 296 | Q9UKF2 | |
| SWQVSARFNQYKYNQ | 3086 | P04114 | |
| KYWRLYQFAFVGLRN | 231 | Q8N1C3 | |
| ESWNLLSRTNYNFQY | 141 | Q86UL3 | |
| WQLSTKEGVRASYNY | 1131 | Q6P158 | |
| FARAYAQGISRTKYW | 181 | O75390 | |
| KINNDFNYEFYNSTW | 191 | P10643 | |
| LSTVSFYNQNKWYLN | 81 | Q56NI9 | |
| YSSYYWIGIRKNNKT | 86 | P16109 | |
| KAVADRYAVYWNSSN | 26 | P52803 | |
| RASQGISSYLAWYQQ | 46 | A0A0C4DH69 | |
| RASQGISNYLAWYQQ | 46 | A0A075B6S5 | |
| RASQSISSYLNWYQQ | 46 | P01597 | |
| YSSNNKNYLAWYQQK | 51 | P06312 | |
| KYWGEIISQQYNFDR | 906 | P14735 | |
| VVYQYWNTKARRNEF | 791 | Q8N766 | |
| YASWAASQINRAYQF | 256 | Q15006 | |
| KYSFQRFYTSWNQEA | 4391 | Q9NZJ4 | |
| RRNWNQYKIQFGNSF | 396 | Q16602 | |
| TRWYFKYFLGQVHQN | 96 | Q5VVW2 | |
| FWLDAYVQYLKGNSQ | 696 | Q3KNS1 | |
| RVAYAWYFSLQKVQG | 2001 | P98161 | |
| TYLALINAVYFKGNW | 176 | Q99574 | |
| FLWKYVNRNDAQSAY | 846 | P22897 | |
| TSASQLEQLNKRYWY | 406 | Q15406 | |
| FPYYRANQRAWQNSI | 66 | A0A1W2PRP0 | |
| QTFALNADRWYQYFT | 96 | Q9NP92 | |
| LNNWSKYYRQTLLFG | 521 | Q68CQ4 | |
| LNYYFNWIKTQLSSQ | 161 | Q9UI12 | |
| RYNNGTWYKIAFQRN | 2381 | P25391 | |
| WNQASINYYTSRGAL | 656 | Q86VE3 | |
| DKTQWRYSYDLNGNI | 2166 | Q9UKZ4 | |
| LTRAYNKASGWSVQY | 2286 | Q9NT68 | |
| LLKWVAYGFQTYFTN | 1256 | Q9NY46 | |
| NGKLYVSYTTNQERW | 296 | Q96QV1 | |
| LSKYTNLLQGWQNRY | 81 | Q9BXB5 | |
| YVRWNYVAKNFAQAL | 291 | O75908 | |
| QWFYNGAILNESKYI | 316 | Q16620 | |
| SRKYVNGSTYQRWQF | 216 | Q6P2Q9 | |
| AYNRFFKESWPQYSQ | 106 | P0CB47 | |
| RQSHDYNWSFKYTGN | 151 | O15270 | |
| QPSRFGNKAYRTWYA | 131 | Q15257 | |
| KMFALRQYYFTNGWN | 1526 | Q9Y5Y9 | |
| YAYDGNRVRKWNVTT | 171 | Q5XPI4 | |
| YQFTVLGQRWYLANF | 426 | Q6UWL2 | |
| YQKYSNNSWRYLSNR | 171 | P01137 | |
| YSVSRFNNLQWYRQN | 46 | A0A075B6U4 | |
| SFQYYNKWAALFGAI | 561 | P55017 | |
| QYGQKQWQSYFGRTF | 81 | Q8N9R8 | |
| QWQSYFGRTFDVYTK | 86 | Q8N9R8 | |
| YLNVYLQWKNNNYST | 1011 | Q92620 | |
| SANFSGVKYIIQWKY | 121 | P08922 | |
| YGYIFSLKNWNSSNI | 46 | Q9BXA5 | |
| GQGVSSWKRAFYYNA | 46 | A0A2R8Y7D0 | |
| IYYQKWINATISRAN | 256 | Q7RTY5 | |
| YFAASSNQRVDLYKW | 76 | Q6PJI9 | |
| QNAKDAVNWLGYAYL | 911 | O75643 | |
| VSKNGFFQGYNRLTW | 231 | Q9Y2D2 | |
| KIFALRQYYFTNGWN | 1416 | Q9UI33 | |
| WFEQRKVYQYSNSRS | 691 | O60315 | |
| NWRLFSKYQYFDSRG | 76 | Q96B42 | |
| QGNSDLYWKAQRYRL | 1051 | Q8TD43 | |
| STWNYQKSTIGAYFL | 471 | Q8NI36 | |
| VAWVLNTYLGKYVNN | 6 | Q5THJ4 | |
| WNTFYQYLQSPFSKF | 186 | Q6P5S2 |